We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Cayman Doxorubicin (Hydrochloride); Purity- Greater Than Or Equal
NETA PART: | CAYM-15007-25 |
MFG.PART: | 15007-25 |
UNSPSC: | 12352200 |
Manufacturer: | Cayman |
Product Description
Empagliflozin-d4 is intended for use as an internal standard for the quantification of empagliflozin (Item No. ) by GC- or LC-MS. Empagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor (IC50 = 3.1 nM for the human transporter). It is selective for SGLT2 over SGLT1, -4, -5, and -6 (IC50s = 8.3, 11, 1.1, and 2 µM, respectively). Dietary administration of empagliflozin (0.03% for 10 weeks) reduces non-fasting blood glucose levels, as well as aortic superoxide levels and cardiac interstitial fibrosis, in db/db mice. It also decreases the severity of glomerulosclerosis, as well as reduces the escape latency in the Morris water maze, in the same model. Formulations containing empagliflozin have been used in the treatment of type 2 diabetes.
WARNING This product is not for human or veterinary use.
Technical Information
- DMSO: Solube
Shipping & Storage Information
SKU | CAYM-15007-25 |
---|---|
Supplier Part Number | 15007-25 |
UM | UNIT |
UNSPSC | 12352200 |
Manufacturer Name | Cayman |
MSDS URL | https://www.caymanchem.com/msdss/15007m.pdf |
Temperature | -20 |
Refrigerated-Frozen | Refrigerated |
CountryOfOrigin | US |
ProductLine | CAYM |
Qty | 25 |
MinOrderQty | 1 |
Weight | 7.00 |
Lead Time | 2 Business Days |
Hazardous | N |
CAS Number | 25316-40-9 |